Exercise testing for risk stratification of ventricular arrhythmias in the athlete

Cardiac Electrophysiology Clinics

Volumn 5, Issue 1, 2013, Pages 53-64

  Schmied, Christian ^a   Brunckhorst, Corinna ^a   Duru, Firat ^a   Haegeli, Laurent ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Catecholaminergic polymorphic ventricular tachycardia (CPVT); Exercise testing; Exercise induced ventricular arrhythmia (EIVA); Premature ventricular beats (PVBs)

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ION; POTASSIUM;

ATHLETE; CARDIOVASCULAR DISEASE; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CHAGAS DISEASE; CLINICAL PROTOCOL; CONGENITAL HEART DISEASE; CYTOSOL; DEFIBRILLATION; EXERCISE; EXERCISE TEST; HEART ATRIUM FIBRILLATION; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HOLTER MONITOR; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC HEART DISEASE; LONG QT SYNDROME; MORTALITY; NONSUSTAINED VENTRICULAR TACHYCARDIA; PATHOPHYSIOLOGY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; REVIEW; RISK ASSESSMENT; RISK FACTOR; SPORTS MEDICINE; SUDDEN DEATH; WOLFF PARKINSON WHITE SYNDROME;

EID: 84874511013     PISSN: 18779182     EISSN: 18779190     Source Type: Journal    
DOI: 10.1016/j.ccep.2012.11.003     Document Type: Review

References (110)

1. Corrado D., Pelliccia A., Bjørnstad H.H., et al. Cardiovascular preparticipation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol: consensus statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005, 26:516-520.
2. Corrado D., Basso C., Thiene G. Assay: sudden death in young athletes. Lancet 2005, 45:47-48.
3. Corrado D., Basso C., Pavei A., et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006, 296:1593-1601.
4. Maron B.J., Haas T.S., Doerer J.J., et al. Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies. Am J Cardiol 2009, 104:276-280.
5. Maron B.J. The paradox of exercise. N Engl J Med 2000, 343:1409-1411.
6. Thompson P.D., Funk E.J., Carleton R.A., et al. Incidence of death during jogging in Rhode Island from 1975 through 1980. JAMA 1982, 247:2535-2538.
7. Siscovick D.S., Weiss N.S., Fletcher R.H., et al. The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med 1984, 311:874-877.
8. Corrado D., Thiene G., Nava A., et al. Sudden death in young competitive athletes: clinico-pathologic correlations in 22 cases. Am J Med 1990, 89:588-596.
9. Maron B.J. Sudden death in young athletes. N Engl J Med 2003, 349:1064-1075.
10. Maron B.J., Thompson P.D., Ackerman M.J., et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2007, 115:1643-1655.
11. Corrado D., Schmied C., Basso C., et al. Risk of sports: do we need a pre-participation screening for competitive and leisure athletes?. Eur Heart J 2011, 32(8):934-944.
12. Corrado D., Migliore F., Basso C., et al. Exercise and the risk of sudden cardiac death. Herz 2006, 31:553-558.
13. Rodgers G.P., Ayanian J.Z., Balady G., et al. American College of Cardiology/American Heart Association Clinical Competence Statement on Stress Testing. A Report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on Clinical Competence. Circulation 2000, 102:1726-1738.
14. Woelfel A., Foster J.R., Simpson R.J., et al. Reproducibility and treatment of exercise-induced ventricular tachycardia. Am J Cardiol 1984, 53:751-756.
15. Califf R.M., McKinnis R.A., McNeer J.F., et al. Prognostic value of ventricular arrhythmias associated with treadmill exercise testing in patients studied with cardiac catheterization for suspected ischemic heart disease. J Am Coll Cardiol 1983, 2(6):1060-1067.
16. Graboys T.B., Lown B., Podrid P.J., et al. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs. Am J Cardiol 1982, 50(3):437-443.
17. Gibbons R.J., Balady G.J., Beasley J.W., et al. ACC/AHA guidelines for exercise testing: a report of the American College of Cardiology/American Heart Association Task force on practice guidelines. J Am Coll Cardiol 1997, 30:260-311. [updated Circulation. 2002;106(14):1883-92].
18. Futterman L.G., Lemberg L. The clinical significance of exercise-induced ventricular arrhythmias. Am J Crit Care 2006, 15:431-435.
19. Selzman K.A., Gettes L.S. Exercise-induced premature ventricular beats: should we do anything differently?. Circulation 2004, 109:2374-2375.
20. Kontula K., Laitinen P.J., Lehtonen A., et al. Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights. Cardiovasc Res 2005, 67:379-387.
21. Beckerman J., Wu T., Jones S., et al. Exercise test-induced arrhythmias. Prog Cardiovasc Dis 2005, 47:285-305.
22. Paffenbarger R.S., Wing A.L., Hyde R.T. Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol 1978, 108(3):161-175.
23. Kim J.H., Malhotra R., Chiampas G., et al. Cardiac arrest during long-distance running races. N Engl J Med 2012, 366(2):130-140.
24. Fazio G., Novo G., Sutera L., et al. Sympathetic tone and ventricular tachycardia. J Cardiovasc Med 2008, 9:963-966.
25. Chen L.S., Zhou S., Fishbein M.C., et al. New perspectives on the role of autonomic nervous system in the genesis of arrhythmias. J Cardiovasc Electrophysiol 2007, 18:123-127.
26. Ueno L.M., Moritani T. Effects of long-term exercise training on cardiac autonomic nervous activities and baroreflex sensitivity. Eur J Appl Physiol 2003, 89:109-114.
27. Iellamo F., Legramante J.M., Pigozzi F., et al. Conversion from vagal to sympathetic predominance with strenuous training in high-performance world class athletes. Circulation 2002, 105:2719-2724.
28. Heidbuchel H., Hoogsteen J., Fagard R., et al. High prevalence of right ventricularinvolvement in endurance athletes with ventricular arrhythmias. Role of an electrophysiologic study in risk stratification. Eur Heart J 2003, 24:1473-1480.
29. O'Keefe J.H., Patil H.R., Lavie C.J., et al. Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin Proc 2012, 87(6):587-595.
30. Nassenstein K., Breuckmann F., Lehmann N., et al. Left ventricular volumes and mass in marathon runners and their association with cardiovascular risk factors. Int J Cardiovasc Imaging 2009, 25(1):71-79.
31. Ector J., Ganame J., van der Merwe N., et al. Reduced right ventricular ejection fraction in endurance athletes presenting with ventricular arrhythmias: a quantitative angiographic assessment. Eur Heart J 2007, 28(3):345-353.
32. Maron B.J., Pelliccia A. The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation 2006, 114(15):1633-1644.
33. Bonifazi M., Sardella F., Lupo C. Preparatory versus main competitions: differences in performances, lactate responses and pre-competition plasma cortisol concentrations in elite male swimmers. Eur J Appl Physiol 2000, 82:368-373.
34. Neilan T.G., Januzzi J.L., Lee-Lewandrowski E., et al. Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon. Circulation 2006, 114(22):2325-2333.
35. Shave R., Baggish A., George K., et al. Exercise-induced cardiac troponin elevation: evidence, mechanisms, and implications. J Am Coll Cardiol 2010, 56(3):169-176.
36. 36th Bethesda Conference: eligibility recommendations for competitive athletes with cardiovascular abnormalitis. J Am Coll Cardiol 2005, 45:1322-1375.
37. Pelliccia A., Fagard R., Bjørnstad H.H., et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005, 226:1422-1445.
38. Elliott P.M., Poloniecki J., Dickie S., et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 2000, 36:2212-2218.
39. Spirito P., Rapezzi C., Autore C., et al. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and non-sustained ventricular tachycardia. Circulation 1994, 90:2743-2747.
40. Monserrat L., Elliott P.M., Gimeno J.R., et al. Nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol 2003, 42:873-879.
41. Maron B.J., Savage D.D., Wolfson J.K., et al. Prognostic significance of 24 h ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am J Cardiol 1981, 48:252-257.
42. Elliott P.M., McKenna W.J. Hypertrophic cardiomyopathy. Lancet 2004, 363:1881-1891.
43. Adabag A.S., Casey S.A., Kuskowski M.A., et al. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol 2005, 45:697-704.
44. Bunch T.J., Chandrasekaran K., Ehrsam J.E., et al. Prognostic significance of exercise induced arrhythmias and echocardiographic variables in hypertrophic cardiomyopathy. Am J Cardiol 2007, 99:835-838.
45. Gimeno J.R., Tomé-Esteban M., Lofiego C., et al. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy. Eur Heart J 2009, 30:2599-2605.
46. Daliento L., Turrini P., Nava A., et al. Arrhythmogenic right ventricular cardiomyopathy in young versus adult patients: similarities and differences. J Am Coll Cardiol 1995, 25:655-664.
47. Marcus F.I., Fontaine G. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: a review. Pacing Clin Electrophysiol 1995, 18:1298-1314.
48. Gemayel C., Pelliccia A., Thompson P.D. Arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2001, 38:1773-1781.
49. Corrado D., Basso C., Nava A., et al. Arrhythmogenic right ventricular cardiomyopathy: current diagnostic and management strategies. Cardiol Rev 2001, 9:259-265.
50. McKenna W.J., Thiene G., Nava A., et al. Task Force of the Working Group on Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J 1994, 71:215-218.
51. Coumel P., Leenhardt A., Haddad G. Exercise ECG: prognostic implications of exercise induced arrhythmias. Pacing Clin Electrophysiol 1994, 17:417-427.
52. Sequeira I.B., Kirsh J.A., Hamilton R.M., et al. Utility of exercise testing in children and teenagers with arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol 2009, 104(3):411-413.
53. Bern C., Montgomery S.P., Herwaldt B.L., et al. Evaluation and treatment of Chagas disease in the United States. A systematic review. JAMA 2007, 298:2171-2181.
54. Milei J., Guerri-Guttenberg R.A., Grana D.R., et al. Prognostic impact of Chagas disease in the United States. Am Heart J 2009, 157:22-29.
55. Dias J.C., Prata A., Correia D. Problems and perspectives for Chagas disease control: in search of a realistic analysis. Rev Soc Bras Med Trop 2008, 41:193-196.
56. Chiale P.A., Halpern S., Nau G.J., et al. Malignant ventricular arrhythmias in chronic chagasic myocarditis. Pacing Clin Electrophysiol 1982, 5:162-172.
57. Rassi A., Rassi A.G., Rassi S.G., et al. Ventricular arrhythmias in Chagas disease. Diagnostic, prognostic and therapeutic aspects. Arq Bras Cardiol 1995, 65:377-387.
58. Beckerman J., Froelicher V.F. Exercise-test-induced arrhythmias: a focused review. ACC Curr J Rev 2005, 12:41-44.
59. Frolkis J.P., Pothier C.E., Blackstone E.H., et al. Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med 2003, 348(9):781-790.
60. Jervell A., Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J 1957, 54(1):59-68.
61. Bianco M., Bria S., Gianfelici A., et al. Does early repolarization in the athlete have analogies with the Brugada syndrome?. Eur Heart J 2001, 22(6):504-510.
62. Walker J., Calkins H., Nazarian S. Evaluation of cardiac arrhythmia among athletes. Am J Med 2010, 123(12):1075-1081.
63. Pelliccia A., Zipes D.P., Maron B.J. Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 2008, 52(24):1990-1996.
64. Viskin S., Rosovski U., Sands A.J., et al. Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one. Heart Rhythm 2005, 2:569-574.
65. Kaufman E.S., Priori S.G., Napolitano C., et al. Electrocardiographic prediction of abnormal genotype in congenital long QT syndrome: experience in 101 related family members. J Cardiovasc Electrophysiol 2001, 12:455-461.
66. Vincent G.M., Timothy K.W., Leppert M., et al. The spectrum of symptoms and QT intervals in carriers of the gene for the Long-QT Syndrome. N Engl J Med 1992, 327:846-852.
67. Ackerman M.J., Splawski I., Makielski J.C., et al. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm 2004, 1:600-607.
68. Wong J.A., Gula L.J., Klein G.J., et al. Utility of treadmill testing in identification and genotype prediction in long-QT syndrome. Circ Arrhythm Electrophysiol 2010, 3(2):120-125.
69. Takenaka K., Ai T., Shimizu W., et al. Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the Long-QT syndrome. Circulation 2003, 107:838-844.
70. Pappone C., Manguso F., Santinelli R., et al. Radiofrequency ablation in children with asymptomatic Wolff-Parkinson-White syndrome. N Engl J Med 2004, 351:1197-1205.
71. Pappone C., Santinelli V., Rosanio S., et al. Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern: results from a large prospective long-term follow-up study. J Am Coll Cardiol 2003, 41:239-244.
72. Sharma A.D., Yee R., Guiraudon G., et al. Sensitivity and specificity of invasive and noninvasive testing for risk of sudden death in Wolff-Parkinson-White syndrome. J Am Coll Cardiol 1987, 10:373-381.
73. Wann L.S., Curtis A.B., January C.T., et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011, 57(2):223.
74. Fuchs T., Torjman A., Galitzkaya L., et al. The clinical significance of ventricular arrhythmias during an exercise test in non-competitive and competitive athletes. Isr Med Assoc J 2011, 13:735-739.
75. Morshedi-Meibodi A., Evans J.C., Levy D., et al. Clinical correlates and prognostic significance of exercise-induced ventricular premature beats in the community: the Framingham Heart Study. Circulation 2004, 109:2417-2422.
76. Kennedy H.L., Whitlock J.A., Sprague M.K., et al. Longterm follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med 1985, 312:193.
77. Elkon K.B., Swerdlow T.A., Myburgh D.P. Persistent ventricular ectopic beats. A long-term study. S Afr Med J 1977, 52:564.
78. Rodstein M., Wolloch L., Gubner R.S. Mortality study of the significance of extrasystoles in an insured population. Circulation 1971, 44:617.
79. Zehender M., Meinertz T., Keul J., et al. ECG variants 1. and cardiac arrhythmias in athletes: clinical relevance and rognostic importance. Am Heart J 1990, 119:1379-1391.
80. Huston P., Puffer J.C., MacMillan R.W. The athletic heart syndrome. N Engl J Med 1985, 315:24-32.
81. Viitasalo M.T., Kala R., Eisalo A. Ambulatory electrocardiographic recording in endurance athletes. Br Heart J 1982, 47:213-220.
82. Bjornstad H., Smith G., Storstein L., et al. Electrocardiographic and echocardiographic findings in top athletes, athletic students and sedentary controls. Cardiology 1993, 82:66-74.
83. Moss A.J. Clinical significance of ventricular arrhythmias in patients with and without coronary artery disease. Prog Cardiovasc Dis 1980, 23:33.
84. Bikkina M., Larson M.G., Levy D. Prognostic implications of asymptomatic ventricular arrhythmias: the Framingham heart study. Ann Intern Med 1992, 117:990.
85. Biffi A., Pelliccia A., Verdile L., et al. Long-term clinical significance of frequent ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol 2002, 40:446-452.
86. Biffi A., Maron B.J., DiGiacinto B., et al. Relation between training-induced left ventricular hypertrophy and risk of ventricular tachyarrhythmias in elite athletes. Am J Cardiol 2008, 101:1792-1795.
87. McHenry P.L., Fisch C., Jordan J.W., et al. Cardiac arrhythmias observed during maximal treadmill exercise testing in clinically normal men. Am J Cardiol 1972, 29:331-336.
88. Marieb M.A., Beller G.A., Gibson R.S., et al. Clinical relevance of exercise-induced ventricular arrhythmias in suspected coronary artery disease. Am J Cardiol 1990, 66:172-178.
89. Schweikert R.A., Pashkow F.J., Snader C.E., et al. Association of exercise-induced ventricular ectopic activity with thallium myocardial perfusion and angiographic coronary artery disease in stable, low-risk populations. Am J Cardiol 1999, 83:530-534.
90. Faris J.V., McHenry P.L., Jordan J.W., et al. Prevalence and reproducibility of exercise-induced ventricular arrhythmias during maximal exercise testing in normal men. Am J Cardiol 1976, 37:617-622.
91. Beckerman J., Mathur A., Stahr S., et al. Exercise-induced ventricular arrhythmias and cardiovascular death. Ann Noninvasive Electrocardiol 2005, 10(1):47-52.
92. Weiner D.A., Levine S.R., Klein M.D., et al. Ventricular arrhythmias during exercise testing: mechanism, response to coronary bypass surgery, and prognostic significance. Am J Cardiol 1984, 53:1553-1557.
93. McHenry P.L., Morris S.N., Kavalier M., et al. Comparative study of exercise-induced ventricular arrhythmias in normal subjects and patients with documented coronary artery disease. Am J Cardiol 1976, 37:609-616.
94. Partington S., Myers J., Cho S., et al. Prevalence and prognostic value of exercise-induced ventricular arrhythmias. Am Heart J 2003, 145:139-146.
95. Sami M., Chaitman B., Fisher L., et al. Significance of exercise-induced ventricular arrhythmia in stable coronary artery disease: a Coronary Artery Surgery Study project. Am J Cardiol 1984, 54:1182-1188.
96. Casella G., Pavesi P.C., Sangiorgio P., et al. Exercise-induced ventricular arrhythmias in patients with healed myocardial infarction. Int J Cardiol 1993, 40:229-235.
97. Udall J.A., Ellestad M.H. Predictive implications of ventricular premature contractions associated with treadmill stress testing. Circulation 1977, 56:985-989.
98. Jouven X., Zureik M., Desnos M., et al. Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations. N Engl J Med 2000, 343:826-833.
99. Coumel P., Fidelle J., Lucet V., et al. Catecholamine-induced severe ventricular arrhythmias with Adam-Stokes in children: report of four cases. Br Heart J 1978, 40:28-37.
100. Leenhardt A., Lucet V., Denjoy I., et al. Catecholaminergic polymorphic ventricular tachycardia in children: a 7-year follow-up of 21 patients. Circulation 1995, 91:1512-1519.
101. Priori S.G., Napolitano C., Tiso N., et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001, 103:196-200.
102. Lahat H., Pras E., Olender T., et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet 2001, 69:1378-1384.
103. Priori S.G., Napolitano C., Memmi M., et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002, 106:69-74.
104. Watanabe H., Chopra N., Laver D., et al. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med 2009, 15:380-383.
105. Hayashi M., Denjoy I., Extramiana F., et al. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Circulation 2009, 119:2426-2434.
106. Sofi F., Capalbo A., Pucci N., et al. Cardiovascular evaluation, including resting and exercise electrocardiography, before participation in competitive sports: cross sectional study. BMJ 2008, 337(7661):88-92.
107. Gibbons R.J., Balady G.J., Bricker J.T., et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines) ACC/AHA 2002 guideline update for exercise testing: summary article. Circulation 2002, 106:1883-1892.
108. Myers J., Froelicher V.F. Optimizing the exercise test for pharmacological investigations. Circulation 1990, 82(5):1839-1846.
109. Furtado E.C., Araujp C.G. Cardiac arrhythmias triggered by sudden and dynamic efforts. Ann Noninvasive Electrocardiol 2010, 15(2):151-156.
110. Young D.Z., Lampert S., Graboys T.B., et al. Safety of maximal exercise testing in patients at high risk for ventricular arrhythmia. Circulation 1984, 70(2):184-191.